Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of LncRNA UCA1 in OSCC CAFs: PD-L1 Upregulation and Tumor Progression. | J Oral Pathol Med | 2025 | 40312741 | PubTator, text mining | PubMed |
| Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p/IKBKB axis. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40259885 | PubTator, text mining | PubMed |
| Long non-coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application. | FEBS Open Bio | 2025 | 40231344 | PubTator, text mining | PubMed |
| Recent progress in exosomal non-coding RNAs research related to idiopathic pulmonary fibrosis. | Front Genet | 2025 | 40212286 | PubTator, text mining | PubMed |
| The Impact of Opioids on Epigenetic Modulation in Myocardial Ischemia and Reperfusion Injury: Focus on Non-coding RNAs. | J Cardiovasc Transl Res | 2025 | 40198537 | PubTator, text mining | PubMed |
| Investigation of Some Long Noncoding RNAs (LncRNAs) in Pediatric Inflammatory Bowel Disease (IBD): An Iranian Study. | Biochem Res Int | 2025 | 40191802 | PubTator, text mining | PubMed |
| Exosomal lncRNAs in the Tumor Angiogenesis: As Therapeutic Targets in Cancer Treatment. | Arch Pharm (Weinheim) | 2025 | 40165644 | PubTator, text mining | PubMed |
| Correction: Neve et al. Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer. Cancers 2018, 10, 440. | Cancers (Basel) | 2025 | 40149385 | PubTator, text mining | PubMed |
| Microenvironmental Modulation for Therapeutic Efficacy of Extracellular Vesicles. | Adv Sci (Weinh) | 2025 | 40145773 | PubTator, text mining | PubMed |
| Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study. | Cancer Cell Int | 2025 | 40016747 | PubTator, text mining | PubMed |
| Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration. | Biomedicines | 2025 | 40002766 | PubTator, text mining | PubMed |
| KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1/p27 axis. | Int J Exp Pathol | 2025 | 39909852 | PubTator, text mining | PubMed |
| The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer. | Biogerontology | 2025 | 39907830 | PubTator, text mining | PubMed |
| β-Asarone Inhibits Carboplatin Resistance in Retinoblastoma Cells Through the UCA1/miR-206/NRP1 Axis. | Biochem Genet | 2025 | 39718722 | PubTator, text mining | PubMed |
| Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics. | Clin Chim Acta | 2025 | 39706249 | PubTator, text mining | PubMed |
| The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability. | Recent Pat Anticancer Drug Discov | 2025 | 39192648 | PubTator, text mining | PubMed |
| Differentially Expressed Blood ARLNC1 in Combination with PCA3/PSA has Reassuring Clinical Applications in the Early Diagnosis of Prostate Cancer in Iranians: A pilot study. | Urol J | 2025 | 39164912 | PubTator, text mining | PubMed |
| Long non-coding RNAs as prognostic biomarkers in non-muscle invasive bladder cancer: A systematic review. | Narra J | 2024 | 39816119 | PubTator, text mining | PubMed |
| PTCSC3, XIST, GAS5, UCA1, and HIFAL: Five lncRNAs Emerging as Potential Prognostic Players in Egyptian Adult Acute Myeloid Leukemia (AML) Patients. | Cancer Control | 2024 | 39673539 | PubTator, text mining | PubMed |
| Identification of urothelial cancer-associated 1 (UCA1) as a diagnostic biomarker of pre-eclampsia via regulating microRNA-16 and its downstream signaling pathway. | Arch Med Sci | 2024 | 39649283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=5